Global Digital Diabetes Management Market 2024-2028

Global Digital Diabetes Management Market 2024-2028

The digital diabetes management market is forecasted to grow by USD 19121.33 mn during 2023-2028, accelerating at a CAGR of 21.99% during the forecast period. The report on the digital diabetes management market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global burden of diabetes, growing awareness of benefits of digital diabetes management, and increasing government support to reduce diabetes.

Technavio's digital diabetes management market is segmented as below:

By End-user

• Hospitals
• Home settings
• Diagnostic centers

By Type

• Wearable devices
• Hand-held devices

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the integration of ai in wearable medical devices as one of the prime reasons driving the digital diabetes management market growth during the next few years. Also, rising adoption of wearable devices and increasing focus on data management will lead to sizable demand in the market.

The report on the digital diabetes management market covers the following areas:

• Digital diabetes management market sizing
• Digital diabetes management market forecast
• Digital diabetes management market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading digital diabetes management market vendors that include Abbott Laboratories, B.Braun SE, Becton Dickinson and Co., DarioHealth Corp., Dassault Systemes SE, decide Clinical Software GmbH, Dexcom Inc., F. Hoffmann La Roche Ltd., Glooko Inc., GlucoMe Ltd., Informed Data Systems Inc. and One Drop., Insulet Corp., LifeScan IP Holdings LLC, Medtronic Plc, Orpyx Medical Technologies Inc., PHC Holdings Corp., Sharecare Inc., SOCIALDIABETES SL, Tandem Diabetes Care Inc., and WaveForm Technologies Inc.. Also, the digital diabetes management market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth